Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_assertion type Assertion NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_head.
- NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_assertion description "[The scenarios involve glutathione-S-transferase theta 1 (GSTT1) and hematopoietic cancer in hospital workers, human leukocyte antigen coding for glutamic acid in the 69th position (HLA DPB1(E69)) and chronic beryllium disease in beryllium workers, and peripheral myelin protein 22 (PMP22) deletion and carpal tunnel syndrome in railroad track workers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_provenance.
- NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_assertion evidence source_evidence_literature NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_provenance.
- NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_assertion SIO_000772 15018031 NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_provenance.
- NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_assertion wasDerivedFrom befree-20150227 NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_provenance.
- NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_assertion wasGeneratedBy ECO_0000203 NP632489.RAHSnjhv9qztZRWnmgmhLgROLHEwsrjm8_XfAdugV1W2E130_provenance.